• LAST PRICE
    1.4000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    1.4500/ 18
  • Ask / Lots
    1.4900/ 2
  • Open / Previous Close
    0.0000 / 1.4000
  • Day Range
    ---
  • 52 Week Range
    Low 1.1900
    High 7.5299
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 1.43
TimeVolumeCTMX
09:32 ET21231.43
09:34 ET60821.44
09:36 ET3001.44
09:38 ET121951.4497
09:39 ET4001.45
09:41 ET22001.44
09:45 ET31001.44
09:48 ET80091.432
09:50 ET58631.445
09:52 ET5001.435
09:54 ET2001.435
09:56 ET24001.43
09:57 ET31621.425
09:59 ET18001.43
10:01 ET3001.425
10:03 ET11001.425
10:06 ET34971.4399
10:08 ET31841.435
10:12 ET2001.44
10:14 ET52931.45
10:17 ET22001.45
10:19 ET21001.46
10:24 ET1001.455
10:32 ET43001.45
10:35 ET2501.4401
10:42 ET27001.435
10:44 ET3001.44
10:46 ET2001.435
10:48 ET13001.43
10:50 ET1001.43
10:51 ET6001.43
10:53 ET1261.43
11:15 ET1001.435
11:18 ET1791.435
11:22 ET1001.435
11:38 ET7001.43
11:40 ET22361.43
11:42 ET2001.425
11:47 ET3171.415
11:54 ET33001.41
11:56 ET12011.41
11:58 ET6001.405
12:00 ET60261.405
12:02 ET61261.405
12:03 ET1001.4
12:05 ET1001.4
12:09 ET248671.405
12:12 ET74001.405
12:16 ET10301.4088
12:18 ET6541.4025
12:21 ET1001.405
12:25 ET51481.405
12:27 ET1001.405
12:34 ET1001.4
12:38 ET32831.41
12:39 ET7091.4091
12:41 ET1001.405
12:54 ET104261.41
12:59 ET7001.42
01:03 ET40001.4143
01:08 ET4411.415
01:10 ET2001.415
01:12 ET2281.4147
01:14 ET1001.415
01:15 ET37471.412
01:17 ET46641.41
01:21 ET13001.405
01:24 ET62361.41
01:26 ET42081.41
01:28 ET1001.415
01:30 ET1001.415
01:32 ET4001.415
01:33 ET7181.42
01:42 ET1001.415
01:50 ET25001.41
02:02 ET2451.41
02:04 ET1001.415
02:11 ET6471.415
02:20 ET4551.41
02:24 ET17571.415
02:27 ET2791.415
02:29 ET6471.415
02:36 ET10001.415
02:38 ET114211.425
02:40 ET1001.43
02:45 ET1001.425
02:54 ET43001.43
02:56 ET114291.43
02:58 ET19001.435
03:05 ET47071.435
03:07 ET20001.4373
03:09 ET67001.425
03:14 ET1001.425
03:16 ET1001.43
03:18 ET5861.421
03:20 ET9001.42
03:21 ET15621.415
03:23 ET24371.415
03:25 ET9131.42
03:32 ET1001.415
03:36 ET4091.415
03:38 ET2861.415
03:43 ET7861.42
03:45 ET288931.4
03:48 ET29711.4
03:52 ET26381.4
03:54 ET15821.4
03:56 ET3551.4
03:57 ET35981.405
03:59 ET77101.4
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCTMX
CytomX Therapeutics Inc
92.3M
-0.9x
---
United StatesFBIO
Fortress Biotech Inc
84.0M
-0.7x
---
United StatesCDXC
Chromadex Corp
81.3M
-2.9x
---
United StatesCLLS
Cellectis SA
110.6M
-1.0x
---
United StatesBIOQ
Bioqual Inc
69.3M
12.6x
+17.04%
United StatesCSBR
Champions Oncology Inc
103.9M
316.8x
---
As of 2022-09-27

Company Information

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company. The Company is developing a class of investigational conditionally activated therapeutics, based on its Probody technology platform, for the treatment of cancer. Its Probody technology platform is designed to enable conditional activation of antibody-based drugs in the tumor microenvironment while minimizing drug activity in healthy tissues and in circulation. The Company's product candidates include the conditionally activated antibody-drug conjugates (ADCs) praluzatamab ravtansine (CX2009, targeting CD166) and CX-2029, targeting CD71, and the Probody immune checkpoint inhibitors pacmilimab (CX-072, targeting PD-L1) and BMS-986249 (targeting CTLA-4). It also has two preclinical agents in investigational new drug (IND)-enabling studies - a conditionally activated ADC targeting EpCAM/Trop-1 (CX-2043) and a conditionally activated T-cell engaging bispecific antibody targeting EGFR and CD3 (CX-904).

Contact Information

Headquarters
650 Gateway Blvd., Suite 125SOUTH SAN FRANCISCO, CA, United States 94080
Phone
650-515-3185
Fax
650-351-0353

Executives

Chairman of the Board, Chief Executive Officer
Sean McCarthy
Chief Financial Officer, Senior Vice President
Carlos Campoy
Senior Vice President, Chief Compliance Officer, General Counsel, Secretary
Lloyd Rowland
Senior Vice President, Chief Medical Officer
Alison Hannah
Senior Vice President, Chief Business Officer and Head of Strategy
Jeffrey Landau

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$92.3M
Revenue (TTM)
$72.6M
Shares Outstanding
66.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.47
EPS
$-1.48
Book Value
$1.37
P/E Ratio
-0.9x
Price/Sales (TTM)
1.3
Price/Cash Flow (TTM)
---
Operating Margin
-134.49%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.